Markets

Helus Pharma Presents Four Posters Evaluating HLP003 To Treat Major Depressive Disorder At Psych Congress 2026

Sep 21, 2026 · 07:38 AM ET· updated 2h ago

Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP) (the "Company" or "Helus Pharma"), a clinical-stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists

Why It Matters

Helus Pharma showed new research about a medicine for depression. Watch if doctors react positively to see if the company is making real progress.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

HELP13.08

+0.71 (+5.72%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.